BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18025995)

  • 1. Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis.
    Mulder WJ; Strijkers GJ; Vucic E; Cormode DP; Nicolay K; Fayad ZA
    Top Magn Reson Imaging; 2007 Oct; 18(5):409-17. PubMed ID: 18025995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.
    Calcagno C; Mani V; Ramachandran S; Fayad ZA
    Angiogenesis; 2010 Jun; 13(2):87-99. PubMed ID: 20526859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques.
    Burtea C; Laurent S; Lancelot E; Ballet S; Murariu O; Rousseaux O; Port M; Vander Elst L; Corot C; Muller RN
    Mol Pharm; 2009; 6(6):1903-19. PubMed ID: 19743879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.
    Briley-Saebo KC; Mulder WJ; Mani V; Hyafil F; Amirbekian V; Aguinaldo JG; Fisher EA; Fayad ZA
    J Magn Reson Imaging; 2007 Sep; 26(3):460-79. PubMed ID: 17729343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging by cardiovascular MR.
    Cyrus T; Lanza GM; Wickline SA
    J Cardiovasc Magn Reson; 2007; 9(6):827-43. PubMed ID: 18066742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging.
    Lipinski MJ; Fuster V; Fisher EA; Fayad ZA
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):48-55. PubMed ID: 16265260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.
    Ala-Korpela M; Sipola P; Kaski K
    Ann Med; 2006; 38(5):322-36. PubMed ID: 16938802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of vulnerable plaque by cardiac magnetic resonance imaging.
    Burgstahler C; Hombach V; Rasche V
    Semin Thromb Hemost; 2007 Mar; 33(2):165-72. PubMed ID: 17340465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate magnetic resonance imaging of atherosclerotic plaques: change future strategies for the diagnosis and therapy of atherosclerotic disease.
    Liu XS; Xu JR
    Med Hypotheses; 2007; 68(3):656-60. PubMed ID: 17014968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional imaging of atherosclerosis to advance vascular biology.
    Sakalihasan N; Michel JB
    Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):728-34. PubMed ID: 19232504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J; Ochoa E; Misselwitz B; Yang D; El Naqa I; Woodard PK; Abendschein D
    Invest Radiol; 2008 Jan; 43(1):49-55. PubMed ID: 18097277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast agents for MRI.
    Waters EA; Wickline SA
    Basic Res Cardiol; 2008 Mar; 103(2):114-21. PubMed ID: 18324367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging.
    Beckmann N; Cannet C; Babin AL; Blé FX; Zurbruegg S; Kneuer R; Dousset V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):272-98. PubMed ID: 20049797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques.
    Wilensky RL; Song HK; Ferrari VA
    J Am Coll Cardiol; 2006 Apr; 47(8 Suppl):C48-56. PubMed ID: 16631510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vascular biology of atherosclerosis and imaging targets.
    Libby P; DiCarli M; Weissleder R
    J Nucl Med; 2010 May; 51 Suppl 1():33S-37S. PubMed ID: 20395349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of atherosclerosis.
    Falk E
    J Am Coll Cardiol; 2006 Apr; 47(8 Suppl):C7-12. PubMed ID: 16631513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
    Stoll G; Bendszus M
    Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.
    Lancelot E; Amirbekian V; Brigger I; Raynaud JS; Ballet S; David C; Rousseaux O; Le Greneur S; Port M; Lijnen HR; Bruneval P; Michel JB; Ouimet T; Roques B; Amirbekian S; Hyafil F; Vucic E; Aguinaldo JG; Corot C; Fayad ZA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):425-32. PubMed ID: 18258820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.